-
NUMBER OF INSIDER BUYING
(Last 12 Months)
3 -
NUMBER OF INSIDER SELLING
(Last 12 Months)
0 -
AMOUNT OF INSIDERS BUYING
(Last 12 Months)
$40.62 M -
AMOUNT OF INSIDERS SELLING
(Last 12 Months)
$0
Viridian Therapeutics, Inc. Insider Transactions
Viridian Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
| Buy | 5,000 @ $23.41 | $117,050 | 6,000 | 09/27/2024 | 09/30/2024 | ||
| Buy | 21,400 @ $23.33 | $499,262 | 21,400 | 09/27/2024 | 09/30/2024 | ||
|
Fairmount Funds Management LLC
Director, 10 percent owner: |
Buy | 1,600,000 @ $18.75 | $30.00 M | 3,445,813 | 09/13/2024 | 09/17/2024 | |
|
Fairmount Funds Management LLC
Director, 10 percent owner, other: See Remarks |
Buy | 476,190 @ $21.00 | $10.00 M | 1,839,954 | 01/22/2024 | 01/24/2024 | |
|
Meisner Lara
Chief Legal Officer |
Sell | 27 @ $28.35 | $765 | 29,971 | 06/16/2023 | 06/20/2023 | |
|
Meisner Lara
Chief Legal Officer |
Sell | 2,269 @ $28.02 | $63,577 | 29,971 | 06/15/2023 | 06/20/2023 | |
|
Meisner Lara
Chief Legal Officer |
Sell | 5,126 @ $25.02 | $128,253 | 29,971 | 06/06/2023 | 06/06/2023 | |
|
Meisner Lara
Chief Legal Officer |
Sell | 499 @ $25.03 | $12,490 | 29,971 | 06/05/2023 | 06/06/2023 | |
|
Meisner Lara
Chief Legal Officer |
Sell | 1,875 @ $24.21 | $45,394 | 29,971 | 06/02/2023 | 06/06/2023 | |
| Buy | 4,000 @ $25.37 | $101,479 | 259,500 | 04/12/2023 | 04/12/2023 | ||
| Buy | 5,500 @ $29.15 | $160,324 | 255,500 | 03/13/2023 | 03/13/2023 | ||
|
Meisner Lara
General Counsel and Secretary |
Sell | 29,971 @ $29.07 | $871,257 | 0 | 03/09/2023 | 03/10/2023 | |
|
Violin Jonathan
Director, Chief Executive Officer |
Sell | 50,000 @ $36.80 | $1.84 M | 430,905 | 02/02/2023 | 02/03/2023 | |
|
Meisner Lara
General Counsel and Secretary |
Sell | 6,843 @ $35.66 | $244,021 | 0 | 01/23/2023 | 01/25/2023 | |
|
Katz Barrett
Chief Medical Officer |
Sell | 24,853 @ $37.21 | $924,780 | 0 | 01/17/2023 | 01/18/2023 | |
|
Katz Barrett
Chief Medical Officer |
Sell | 47,377 @ $35.30 | $1.67 M | 0 | 01/10/2023 | 01/11/2023 | |
|
Meisner Lara
General Counsel and Secretary |
Sell | 16,326 @ $29.19 | $476,556 | 0 | 12/21/2022 | 12/22/2022 | |
|
Meisner Lara
General Counsel and Secretary |
Sell | 1,297 @ $28.44 | $36,887 | 0 | 12/16/2022 | 12/19/2022 | |
|
Meisner Lara
General Counsel and Secretary |
Sell | 15,656 @ $28.12 | $440,247 | 0 | 12/14/2022 | 12/14/2022 | |
|
Meisner Lara
General Counsel and Secretary |
Sell | 8,125 @ $22.05 | $179,156 | 0 | 11/15/2022 | 11/16/2022 |
Viridian Therapeutics, Inc. Frequently Asked Questions
-
Who is on Viridian Therapeutics, Inc.'s Insider Roster?
The list of insiders at Viridian Therapeutics, Inc. includes Fairmount Funds Management LLC, Mahoney Stephen F., Beetham Thomas W..
-
How much insider buying is happening at Viridian Therapeutics, Inc.?
Insiders have purchased a total of 2.10 M Viridian Therapeutics, Inc. shares in the last 12 months for a total of 40.62 M sold.
-
Which Viridian Therapeutics, Inc. insiders have been buying company stock?
The following insiders have purchased Viridian Therapeutics, Inc. shares in the last 12 months: Fairmount Funds Management LLC ($40.00 M), Mahoney Stephen F. ($499,262), Beetham Thomas W. ($117,050),